Beijing Winsunny Pharmaceutical CO.LTD Asset Resilience Ratio
Beijing Winsunny Pharmaceutical CO.LTD asset resilience ratio. Beijing Winsunny Pharmaceutical CO.LTD (601089) has an Asset Resilience Ratio of 10.89% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Beijing Winsunny Pharmaceutical CO.LTD defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)
Asset resilience ratio of Beijing Winsunny Pharmaceutical CO.LTD from 2020 to 2024. This chart shows how Beijing Winsunny Pharmaceutical CO.LTD's Asset Resilience Ratio has changed over time. Read 601089 total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Beijing Winsunny Pharmaceutical CO.LTD's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Beijing Winsunny Pharmaceutical CO.LTD (601089) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥511.00 Million | 10.89% |
| Total Liquid Assets | CN¥511.00 Million | 10.89% |
Asset Resilience Insights
- Moderate Liquidity: Beijing Winsunny Pharmaceutical CO.LTD has 10.89% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Beijing Winsunny Pharmaceutical CO.LTD Industry Peers by Asset Resilience Ratio
Compare Beijing Winsunny Pharmaceutical CO.LTD's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Ajanta Pharma Limited
NSE:AJANTPHARM |
Drug Manufacturers - Specialty & Generic | 14.99% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Porton Fine Chemicals Ltd
SHE:300363 |
Drug Manufacturers - Specialty & Generic | 6.85% |
|
Jubilant Pharmova Limited
NSE:JUBLPHARMA |
Drug Manufacturers - Specialty & Generic | 1.26% |
Beijing Winsunny Pharmaceutical CO.LTD Asset Resilience Ratio by Year (2020–2024)
Beijing Winsunny Pharmaceutical CO.LTD asset resilience ratio by year from 2020 to 2024. The table below shows the annual Asset Resilience Ratio data for Beijing Winsunny Pharmaceutical CO.LTD.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 32.78% | CN¥1.58 Billion ≈ $231.06 Million |
CN¥4.82 Billion ≈ $704.82 Million |
+28.14pp |
| 2021-12-31 | 4.64% | CN¥100.00 Million ≈ $14.63 Million |
CN¥2.15 Billion ≈ $315.08 Million |
+1.73pp |
| 2020-12-31 | 2.91% | CN¥50.00 Million ≈ $7.32 Million |
CN¥1.72 Billion ≈ $251.21 Million |
-- |
About Beijing Winsunny Pharmaceutical CO.LTD
Beijing Foyou Pharma CO.,LTD engages in the research and development, production, and sale of pharmaceutical preparations and medical devices China and internationally. The company provides chemical drugs and traditional chinese medicines. Its products used in cardiovascular kind, chronic kidney disease, skin disease, digestive system, diabetes, neuropsychiatric system kind, mental nervous system… Read more